Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 |
| | 10-K | 10-K | 10-K/A | 10-K/A | 10-K/A | 10-K | 10-K | 10-K |
| Revenues: |
| United States | 3.5 | 4.9 | | | 1.1 | 0.6 | 0.4 | 0.5 |
| Germany | | | | | 0.4 | 1.1 | 0.6 | 1.3 |
| Other | | 0.2 | | | | | | |
| Total revenues [+] | 3.5 | 5.0 | 2.3 | 2.3 | 1.5 | 1.7 | 1.0 | 1.9 |
| Products | | | | | | | | 1.9 |
| Revenue growth [+] | -30.1% | 114.3% | 3.4% | 48.9% | -8.4% | 58.9% | -43.9% | -31.2% |
| United States | -27.7% | | | | 95.2% | 47.1% | -27.4% | |
| Germany | | | | | -64.6% | 66.1% | -50.7% | |
| Cost of goods sold | 0.0 | 0.0 | 2.2 | 1.2 | 1.1 | 1.6 | 1.3 | 1.4 |
| Gross profit | 3.5 | 5.0 | 0.2 | 1.1 | 0.5 | 0.1 | -0.2 | 0.4 |
| Gross margin | 100.0% | 100.0% | 7.0% | 47.4% | 30.0% | 6.3% | -20.2% | 23.2% |
| Selling, general and administrative [+] | 2.4 | 2.8 | 4.7 | 4.4 | 5.0 | 4.8 | 7.6 | 9.7 |
| Sales and marketing | 0.1 | 0.3 | 1.1 | 1.0 | 1.1 | 0.8 | 2.2 | 2.6 |
| General and administrative | 2.3 | 2.5 | 3.6 | 3.4 | 3.9 | 3.9 | 5.4 | 7.1 |
| Research and development | 0.4 | 0.7 | 1.0 | 1.6 | 1.7 | 1.4 | 2.0 | 1.9 |
| Other operating expenses | 0.6 | 0.5 | | 0.4 | | 0.3 | 0.3 | |
| EBITDA [+] | 0.3 | 1.4 | -4.5 | -4.3 | -5.2 | -5.3 | -9.0 | -9.9 |
| EBITDA growth | -75.1% | -130.6% | 4.0% | -16.5% | -1.6% | -41.2% | -9.7% | -26.4% |
| EBITDA margin | 9.8% | 27.5% | -192.4% | -191.3% | -341.2% | -317.4% | -858.4% | -533.6% |
| Depreciation | 0.0 | 0.0 | 0.0 | 0.0 | 1.0 | 1.0 | 1.1 | 1.1 |
| EBITA | 0.3 | 1.3 | -4.5 | -4.4 | -6.2 | -6.3 | -10.1 | -11.1 |
| EBITA margin | 9.6% | 26.8% | -194.1% | -192.9% | -406.2% | -378.3% | -962.0% | -594.8% |
| Amortization of intangibles | 0.3 | 0.4 | 0.9 | 0.9 | | | | |
| EBIT [+] | 0.1 | 1.0 | -5.5 | -5.3 | -6.2 | -6.3 | -10.1 | -11.1 |
| EBIT growth | -92.6% | -117.7% | 3.1% | -14.1% | -1.7% | -37.5% | -9.3% | -24.1% |
| EBIT margin | 2.1% | 19.3% | -233.8% | -234.4% | -406.2% | -378.3% | -962.0% | -594.8% |
| Non-recurring items [+] | 3.4 | | | | | | | 3.1 |
| Asset impairment | 3.4 | | | | | | | 3.1 |
| Interest expense, net [+] | | 0.0 | 4.4 | 4.4 | | | | 2.6 |
| Interest expense | | | 4.4 | 4.4 | | | | 2.6 |
| Interest income | | 0.0 | | | | | | |
| Other income (expense), net [+] | 0.9 | 26.8 | -9.5 | 8.8 | 41.3 | 6.2 | 2.0 | -15.1 |
| Gain (loss) on investments | -0.1 | | | | | | 0.3 | |
| Gain (loss) on debt retirement | 4.2 | 0.1 | -27.5 | -2.6 | -6.0 | | 2.4 | 0.3 |
| Gain (loss) on derivative instruments | 0.6 | 3.1 | 11.3 | -12.2 | 11.6 | | | |
| Other | 0.9 | 26.8 | -13.9 | 4.5 | | | | |
| Pre-tax income | -2.5 | 27.8 | -19.4 | -0.8 | 35.1 | -0.1 | -8.0 | -31.9 |
| Income taxes | 0.0 | -0.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 8.7 |
| Tax rate | 0.0% | | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Earnings from continuing ops | | -0.7 | -19.4 | -0.8 | 32.6 | -68.3 | -9.6 | -42.3 |
| Earnings from discontinued ops | -2.5 | 28.5 | | | | -0.1 | | |
| Net income | -2.5 | 27.7 | -19.4 | -0.8 | 32.6 | -68.4 | -9.6 | -42.3 |
| Net margin | -70.2% | 551.8% | -827.0% | -37.5% | 2141.3% | -4112.8% | -916.8% | -2271.0% |
| |
| Basic EPS [+] | $0.00 | $0.00 | ($0.02) | $0.00 | $1.44 | ($3,403.34) | $0.00 | ($40,635.00) |
| Growth | -100.0% | -82.2% | 267.1% | -100.3% | -100.0% | 41445413273.3% | -100.0% | 36447014.9% |
| Diluted EPS [+] | $0.00 | $0.00 | ($0.02) | $0.00 | $0.05 | ($3,403.34) | $0.00 | ($0.05) |
| Growth | -100.0% | -82.2% | 267.1% | -108.0% | -100.0% | 41445413273.3% | -100.0% | -56.4% |
| |
| Shares outstanding (basic) [+] | 1,585.8 | 274.6 | 1,276.6 | 205.2 | 22.7 | 0.0 | 1,167,856.3 | 0.0 |
| Growth | 477.4% | -78.5% | 522.1% | 804.8% | 112938.5% | -100.0% | 112106593872.8% | -100.0% |
| Shares outstanding (diluted) [+] | 1,585.8 | 274.6 | 1,276.6 | 205.2 | 629.7 | 0.0 | 1,167,856.3 | 871.1 |
| Growth | 477.4% | -78.5% | 522.1% | -67.4% | 3138157.2% | -100.0% | 133966.9% | 42.0% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|